Neuromelanin-Sensitive MRI Identified as a Potential Biomarker for Psychosis NIH-funded study found Neuromelanin-sensitive MRI able to measure dopamine function associated with psychosis Researchers have shown that a type of magnetic resonance imaging — called neuromelanin-sensitive MRI (NM-MRI) — is a potential biomarker for psychosis. NM-MRI signal was found to be a marker of dopamine function in people with schizophrenia and an indicator of the severity of psychotic symptoms in people with this mental illness. Learn More >>   Questions? Contact Us STAY CONNECTED: SUBSCRIBER SERVICES: Manage Preferences  |  Unsubscribe  |  Help  |  Subscribe to DSIR Portfolio Snapshots     This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Mental Health · 6001 Executive Boulevard · Bethesda, MD 20892-9663 · 1-866-615-6464